Middle East and Africa Obesity Treatment Market

Published Apr 01, 2025

Length 350 Pages

SKU # DAABD20406820

Description

Middle East and Africa obesity treatment market is expected to reach USD 4,813.80 thousand by 2032 from USD t 1,798.11 housand in 2024, growing at a CAGR of 13.1% in the forecast period of 2025 to 2032.
Market Segmentation:
Middle East and Africa Obesity Treatment Market, Treatment Type (Pharmacological Treatments (Anti-obesity Drugs), Bariatric Surgery, Behavioral & Lifestyle Therapy, Non-Invasive/ Endoscopic Procedures, and Medical Devices & Technologies), Age Group (Adult Obesity Treatment, Geriatric Obesity Treatment, and Pediatric Obesity Treatment), Distribution Channel (Online Pharmacies, Retail Pharmacies, Weight Management Clinics, Hospital Pharmacies, and Wellness & Fitness Centers), Patient Type (Class III, Class II, and Class I), Country (Saudi Arabia, U.A.E., South Africa, Egypt, Kuwait, Israel, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032

Overview of Middle East and Africa Obesity Treatment market Dynamics:

Driver

• Integration of Digital Health Solutions in Obesity Treatment

Restraint

• Anti-Obesity Drugs and Surgical Interventions Carry Risks

Opportunity

• Increasing Prevalence of Lifestyle Related Diseases

Market Players:

The key market players operating in the Middle East and Africa Obesity Treatment market are listed below:

• Novo Nordisk A/S
• Eli Lilly and Company
• Medtronic Plc.
• Boston Scientific Corporation
• Johnson & Johnson Services, Inc.
• AstraZeneca
• Sanofi
• Allurion Technologies
• F. HOFFMANN LA-ROCHE AG
• GSK plc

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The Middle East And Africa Obesity Treatment Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Multivariate Modelling; 2.6 Treatment Type Lifeline Curve; 2.7 Primary Interviews With Key Opinion Leaders; 2.8 Dbmr Market Position Grid; 2.9 Market End User Coverage Grid; 2.10 Vendor Share Analysis; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Porter’s Five Forces; 4.2 Pestel Analysis; 4.3 Epidemiology: Middle East And Africa Obesity Treatment Market; 4.4 Drug Treatment Rate By Matured Markets: Middle East And Africa Obesity Treatment Market; 4.5 Drug; 4.6 Word Pipeline
5 Regulatory Framework For The Middle East And Africa Obesity Treatment Market: 5.1 Regulatory Approval Pathways; 5.2 Licensing And Registration; 5.3 Regulatory Approval Pathways; 5.4 Licensing And Registration; 5.5 Good Manufacturing Practices (Gmps) Guidelines
6 Market Overview: 6.1 Drivers; 6.1.1 Increasing Prevalence Of Obesity; 6.1.2 Innovations In Anti-obesity Medications; 6.1.3 Growth In Bariatric And Metabolic Surgeries.; 6.1.4 Integration Of Digital Health Solutions In Obesity Treatment; 6.2 Restraints; 6.2.1 Anti-obesity Drugs And Surgical Interventions Carry Risks; 6.2.2 High Relapse Rates Post-treatment Of Obesity; 6.3 Opportunities; 6.3.1 Increasing Prevalence Of Lifestyle Related Diseases; 6.3.2 Rising Disposable Income Enhancing The Purchasing Power For Obesity Treatment Related Products; 6.3.3 Rise In Strategic Initiatives And Launches By Market Players; 6.4 Challenges; 6.4.1 Long-term Follow-ups Associated With Obesity Treatment; 6.4.2 Addressal Of The Lifestyle And Behavioral Changes
7 Middle East And Africa Obesity Treatment Market, By Treatment Type: 7.1 Overview; 7.2 Pharmacological Treatments (Anti-obesity Drugs); 7.2.1 Glp-1 Receptor Agonists; 7.2.2 Dual Gip/ Glp-1 Receptor Agonists; 7.2.2.1 Phentermine; 7.2.2.2 Phentermine-topiramate; 7.2.2.3 Naltrexone-bupropion; 7.2.3 Lipase Inhibitors; 7.2.4 Deoxycholic Acid; 7.2.5 Others; 7.3 Bariatric Surgery; 7.3.1 Restrictive Surgeries; 7.3.1.1 Sleeve Gastrectomy; 7.3.1.2 Adjustable Gastric Banding; 7.3.2 Combination Surgeries; 7.3.2.1 Roux-en-y Gastric Bypass (Rygb); 7.3.2.2 Mini-gastric Bypass (Mgb); 7.3.3 Malabsorptive Surgeries; 7.3.3.1 Laparoscopic Surgery; 7.3.3.2 Robotic-assisted Surgery; 7.3.3.3 Open Surgery; 7.4 Behavioral & Lifestyle Therapy; 7.4.1 Dietary Interventions; 7.4.2 Behavioral Modification Therapy; 7.4.3 Physical Activity Programs; 7.4.4 Psychological Counseling; 7.5 Non-invasive/ Endoscopic Procedures; 7.5.1 Endoscopic Sleeve Gastroplasty (Esg); 7.5.2 Intragastric Balloon (Igb); 7.5.2.1 Orbera Intragastric Balloon; 7.5.2.2 Spatz Adjustable Balloon System; 7.5.3 Aspiration Therapy (Aspireassist); 7.5.4 Transoral Gastroplasty (Toga); 7.6 Medical Devices & Technologies; 7.6.1 Artificial Intelligence & Digital Weight Management Platforms; 7.6.2 Gastric Electrical Stimulation Devices (Maestro System)
8 Middle East And Africa Obesity Treatment Market, By Age Group: 8.1 Overview; 8.2 Adult Obesity Treatment; 8.3 Geriatric Obesity Treatment; 8.4 Pediatric Obesity Treatment
9 Middle East And Africa Obesity Treatment Market, By Distribution Channel: 9.1 Overview; 9.2 Online Pharmacies; 9.3 Retail Pharmacies; 9.4 Weight Management Clinics; 9.5 Hospital Pharmacies; 9.6 Wellness & Fitness Centers
10 Middle East And Africa Obesity Treatment Market, By Patient Type: 10.1 Overview; 10.2 Class Iii; 10.3 Class Ii; 10.4 Class I
11 Middle East And Africa Obesity Treatment Market, By Region: 11.1 Middle East And Africa; 11.1.1 Saudi Arabia; 11.1.2 Egypt; 11.1.3 Kuwait; 11.1.4 South Africa; 11.1.5 United Arab Emirates; 11.1.6 Israel; 11.1.7 Rest Of Middle East And Africa
12 Middle East And Africa Obesity Treatment Market, Company Landscape: 12.1 Company Share Analysis: Middle East And Africa
13 Swot Analysis
14 Company Profile: 14.1 Novo Nordisk A/S; 14.1.1 Company Snapshot; 14.1.2 Revenue Analysis; 14.1.3 Company Share Analysis; 14.1.4 Product Portfolio; 14.1.5 Recent Development; 14.2 Eli Lilly And Company; 14.2.1 Company Snapshot; 14.2.2 Revenue Analysis; 14.2.3 Company Share Analysis; 14.2.4 Product Portfolio; 14.2.5 Recent Development/News; 14.3 Medtronic; 14.3.1 Company Snapshot; 14.3.2 Revenue Analysis; 14.3.3 Company Share Analysis; 14.3.4 Product Portfolio; 14.3.5 Recent Development; 14.4 Boston Scientific Corporation; 14.4.1 Company Snapshots; 14.4.2 Revenue Analysis And Segmented Analysis; 14.4.3 Company Share Analysis; 14.4.4 Product Portfolio; 14.4.5 Recent Development; 14.5 Johnson & Johnson Services, Inc.; 14.5.1 Company Snapshot; 14.5.2 Revenue Analysis; 14.5.3 Company Share Analysis; 14.5.4 Product Portfolio; 14.5.5 Recent Development/News; 14.6 Altimmune; 14.6.1 Company Snapshot; 14.6.2 Pipeline Portfolio; 14.6.3 Recent Updates; 14.7 Astrazeneca; 14.7.1 Company Snapshot; 14.7.2 Revenue Analysis; 14.7.3 Product Portfolio; 14.7.4 Recent Development/News; 14.8 Allurion; 14.8.1 Company Snapshot; 14.8.2 Revenue Analysis; 14.8.3 Product Portfolio; 1.1.5 Recent Development/News; 14.9 Amgen; 14.9.1 Company Snapshot; 14.9.2 Revenue Analysis; 14.9.3 Product Portfolio; 1.1.13 Recent Development/News; 14.10 Arena Pharmaceuticals Ltd; 14.10.1 Company Snapshot; 14.10.2 Product Portfolio; 14.10.3 Recent Development; 14.11 Currax Pharmaceuticals Llc; 14.11.1 Company Snapshot; 14.11.2 Product Portfolio; 14.11.3 Recent Development; 14.12 Cousin Surgery; 14.12.1 Company Snapshot; 14.12.2 Product Portfolio; 14.12.3 Recent Development; 14.13 F. Hoffmann-la Roche Ltd; 14.13.1 Company Snapshot; 14.13.2 Revenue Analysis; 14.13.3 Product Portfolio; 14.13.4 Recent Development/News; 14.14 Fitterfly Healthtech Pvt. Ltd.; 14.14.1 Company Snapshot; 14.14.2 Product Portfolio; 14.14.3 Recent Development; 14.15 Morphic Medical, Inc; 14.15.1 Company Snapshot; 14.15.2 Product Portfolio; 14.15.3 Recent Development; 14.16 Noom, Inc.; 14.16.1 Company Snapshot; 14.16.2 Product Portfolio; 14.16.3 Recent Development; 14.17 Omada Health Inc; 14.17.1 Company Snapshot; 14.17.2 Product Portfolio; 14.17.3 Recent Development; 14.18 Reshape Lifesciences; 14.18.1 Company Snapshot; 14.18.2 Revenue Analysis; 14.18.3 Product Portfolio; 1.1.7 Recent Development/News; 14.19 Raziel; 14.19.1 Company Snapshot; 14.19.2 Product Portfolio; 14.19.3 Recent Development; 14.20 Spatz Fgia Inc.; 14.20.1 Company Snapshot; 14.20.2 Product Portfolio; 14.20.3 Recent Development; 14.21 Sanofi; 14.21.1 Company Snapshot; 14.21.2 Revenue Analysis; 14.21.3 Product Portfolio; 14.21.4 Recent Development; 14.22 Saniona; 14.22.1 Company Snapshot; 14.22.2 Revenue Analysis; 14.22.3 Product Portfolio; 14.22.4 Recent Development; 14.23 Usgi Medical; 14.23.1 Company Snapshot; 14.23.2 Product Portfolio; 14.23.3 Recent Development; 14.24 Vivus Llc.; 14.24.1 Company Snapshot; 14.24.2 Product Portfolio; 14.24.3 Recent Development/News; 14.25 Viking Therapeutics; 14.25.1 Company Snapshots; 14.25.2 Revenue Analysis; 14.25.3 Product Portfolio; 14.25.4 Recent Development; 14.26 Zealand Pharma; 14.26.1 Company Snapshot; 14.26.2 Revenue Analysis; 14.26.3 Product Portfolio; 14.26.4 Recent Development/News
15 Questionnaire
16 Related Reports
List Of Tables: Table 1 Obesity Prevalence By Region (Adults); Table 2 Obesity Prevalence By Gender (Adults); Table 3 Obesity Prevalence By Age (Adults); Table 4 Europe Clinical Trial Market For Obesity Treatment; Table 5 Distribution Of Products And Projects By Phase Europe Obesity Treatment Market; Table 6 Distribution Of Projects By Therapeutic Area And Phase Europe Obesity Treatment Market; Table 7 Europe Obesity Statistics (2022); Table 8 Europe Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 9 Europe Pharmacological Treatments (Anti-obesity Drugs) In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 10 Europe Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 11 Europe Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 12 Europe Bariatric Surgery In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 13 Europe Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 14 Europe Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 15 Europe Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 16 Europe Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 17 Europe Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 18 Europe Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 19 Europe Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 20 Europe Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 21 Europe Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 22 Europe Medical Devices & Technologies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 23 Europe Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 24 Europe Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 25 Europe Adult Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 26 Europe Geriatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 27 Europe Pediatric Obesity Treatment In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 28 Europe Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 29 Europe Online Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 30 Europe Retail Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 31 Europe Weight Management Clinics In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 32 Europe Hospital Pharmacies In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 33 Europe Wellness & Fitness Centers In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 34 Europe Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 35 Europe Class Iii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 36 Europe Class Ii In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 37 Europe Class I In Obesity Treatment Market, By Region, 2018-2032 (Usd Thousand); Table 38 Europe Obesity Treatment Market, By Country, 2018-2032 (Usd Thousand); Table 39 Europe Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 40 Europe Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 41 Europe Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 42 Europe Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 43 Europe Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 44 Europe Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 45 Europe Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 46 Europe Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 47 Europe Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 48 Europe Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 49 Europe Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 50 Europe Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 51 Europe Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 52 Europe Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 53 United Kingdom Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 54 United Kingdom Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 55 United Kingdom Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 56 United Kingdom Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 57 United Kingdom Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 58 United Kingdom Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 59 United Kingdom Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 60 United Kingdom Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 61 United Kingdom Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 62 United Kingdom Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 63 United Kingdom Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 64 United Kingdom Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 65 United Kingdom Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 66 United Kingdom Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 67 Germany Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 68 Germany Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 69 Germany Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 70 Germany Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 71 Germany Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 72 Germany Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 73 Germany Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 74 Germany Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 75 Germany Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 76 Germany Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 77 Germany Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 78 Germany Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 79 Germany Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 80 Germany Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 81 France Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 82 France Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 83 France Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 84 France Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 85 France Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 86 France Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 87 France Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 88 France Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 89 France Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 90 France Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 91 France Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 92 France Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 93 France Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 94 France Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 95 Italy Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 96 Italy Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 97 Italy Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 98 Italy Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 99 Italy Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 100 Italy Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 101 Italy Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 102 Italy Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 103 Italy Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 104 Italy Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 105 Italy Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 106 Italy Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 107 Italy Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 108 Italy Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 109 Spain Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 110 Spain Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 111 Spain Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 112 Spain Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 113 Spain Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 114 Spain Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 115 Spain Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 116 Spain Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 117 Spain Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 118 Spain Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 119 Spain Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 120 Spain Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 121 Spain Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 122 Spain Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 123 Russia Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 124 Russia Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 125 Russia Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 126 Russia Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 127 Russia Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 128 Russia Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 129 Russia Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 130 Russia Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 131 Russia Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 132 Russia Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 133 Russia Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 134 Russia Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 135 Russia Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand); Table 136 Russia Obesity Treatment Market, By Patient Type, 2018-2032 (Usd Thousand); Table 137 Turkey Obesity Treatment Market, By Treatment Type, 2018-2032 (Usd Thousand); Table 138 Turkey Pharmacological Treatment (Anti-obesity Drugs) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 139 Turkey Centrally Acting Anorectics In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 140 Turkey Bariatric Surgery In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 141 Turkey Restrictive Surgeries In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 142 Turkey Combination Surgeries In Obesity Treatment Market, By Class, 2018-2032 (Usd Thousand); Table 143 Turkey Bariatric Surgery In Obesity Treatment Market, By Approach, 2018-2032 (Usd Thousand); Table 144 Turkey Behavioral & Lifestyle Therapy In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 145 Turkey Non-invasive/ Endoscopic Procedures In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 146 Turkey Intragastric Balloon (Igb) In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 147 Turkey Medical Devices & Technologies In Obesity Treatment Market, By Type, 2018-2032 (Usd Thousand); Table 148 Turkey Obesity Treatment Market, By Age Group, 2018-2032 (Usd Thousand); Table 149 Turkey Obesity Treatment Market, By Distribution Channel, 2018-2032 (Usd Thousand)
List Of Figures: Figure 1 Middle East And Africa Obesity Treatment Market: Segmentation; Figure 2 Middle East And Africa Obesity Treatment Market: Data Triangulation; Figure 3 Middle East And Africa Obesity Treatment Market: Droc Analysis; Figure 4 Middle East And Africa Obesity Treatment Market: Regional Market Analysis; Figure 5 Middle East And Africa Obesity Treatment Market: Company Research Analysis; Figure 6 Middle East And Africa Obesity Treatment Market: Lifeline Curve; Figure 7 Middle East And Africa Obesity Treatment Market: Interview Demographics; Figure 8 Middle East And Africa Obesity Treatment Market: Dbmr Market Position Grid; Figure 9 Middle East And Africa Obesity Treatment Market: Market End User Coverage Grid; Figure 10 Middle East And Africa Obesity Treatment Market: Vendor Share Analysis; Figure 11 Middle East And Africa Obesity Treatment Market: Segmentation; Figure 12 Middle East And Africa Obesity Treatment Market Executive Summary; Figure 13 Strategic Decisions; Figure 14 Five Segments Comprise The Middle East And Africa Obesity Treatment Market , By Treatment Type; Figure 15 Rising Prevalence Of Obesity Is Expected To Drive The Growth Of Middle East And Africa Obesity Treatment Market From 2025 To 2032; Figure 16 The Pharmacological Treatments (Anti-obesity Drugs) Segment Is Expected To Account For The Largest Share Of The Middle East And Africa Obesity Treatment Market In 2025 - 2032; Figure 17 Market Overview; Figure 18 Prevalence Of Obesity In Adults Age 20 And Older, By Sex And Age: United States, August 2021–august 2023 Source: Centers For Disease Control And Prevention.; Figure 19 Share Of Pre-obese And Obese Persons Aged 16 Years Or Over, By Sex, 2022 (%); Figure 20 Middle East And Africa Obesity Treatment Market: By Treatment Type, 2024; Figure 21 Middle East And Africa Obesity Treatment Market: By Treatment Type, 2025-2032 (Usd Thousand); Figure 22 Middle East And Africa Obesity Treatment Market: By Treatment Type, Cagr (2025-2032); Figure 23 Middle East And Africa Obesity Treatment Market: By Treatment Type, Lifeline Curve; Figure 24 Middle East And Africa Obesity Treatment Market: By Age Group, 2024; Figure 25 Middle East And Africa Obesity Treatment Market: By Age Group, 2025-2032 (Usd Thousand); Figure 26 Middle East And Africa Obesity Treatment Market: By Age Group, Cagr (2025-2032); Figure 27 Middle East And Africa Obesity Treatment Market: By Age Group, Lifeline Curve; Figure 28 Middle East And Africa Obesity Treatment Market: By Distribution Channel, 2024; Figure 29 Middle East And Africa Obesity Treatment Market: By Distribution Channel, 2025-2032 (Usd Thousand); Figure 30 Middle East And Africa Obesity Treatment Market: By Distribution Channel, Cagr (2025-2032); Figure 31 Middle East And Africa Obesity Treatment Market: By Distribution Channel, Lifeline Curve; Figure 32 Middle East And Africa Obesity Treatment Market: By Patient Type, 2024; Figure 33 Middle East And Africa Obesity Treatment Market: By Patient Type, 2025-2032 (Usd Thousand); Figure 34 Middle East And Africa Obesity Treatment Market: By Patient Type, Cagr (2025-2032); Figure 35 Middle East And Africa Obesity Treatment Market: By Patient Type, Lifeline Curve; Figure 36 Middle East And Africa Obesity Treatment Market: Snapshot (2024); Figure 37 Middle East And Africa Obesity Treatment Market: Company Share 2024 (%)

Pricing

Currency Rates

Single User Email from Publisher $3,500
Global Site License Email from Publisher $4,200

How Do Licenses Work?

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

Chat Now